Focal/Grid Photocoagulation vs. Intravitreal Triamcinolone for Treatment of Diabetic Macular Edema
March 12, 2009
The March 2009 issue of The Archives of Ophthalmology contains a report on the 3-year outcomes of patients who participated in a randomized trial evaluating 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone compared with focal/grid photocoagulation for treatment of diabetic macular edema.
Eyes with diabetic macular edema and visual acuities of 20/40 to 20/320 were randomly assigned to focal/grid photocoagulation or 1 mg or 4 mg of triamcinolone. At the conclusion of the trial, 3-year follow-up data were available in 306 eyes.
Results did not indicate a long-term benefit of intravitreal triamcinolone relative to focal/grid photocoagulation in patients with diabetic macular edema.
Read the full report.
You might also enjoy...
- Intravitreal Triamcinolone vs. Focal Laser for Diabetic Macular Edema
- Do Triamcinolone Injections Improve Vision After Central Retinal Vein Occlusion?
- Study Indicates Avastin (bevacizumab) May Work for Diabetic Macular Edema
- Is Ranibizumab Superior to Laser for DME?
- Is Avastin Better for CSME?
Comments
Jump down to form below to submit your own comments
Subscribe for Free!
